{"nct_id":"NCT01416428","title":"Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies","status":"TERMINATED","status_verified_date":"2022-11","start_date":"2011-10-15","start_date_type":"ACTUAL","primary_completion_date":"2016-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}